in vivo-jetPEI®-Gal is a galactose-conjugated in vivo-jetPEI® derivative designed to enhance delivery to cells expressing galactose-specific membrane lectins, such as the asialoglycoprotein receptor (ASGP-R or Gal/GalNAc receptor).
- Suitable for in vivo delivery of any nucleic acid
- Very simple to use: two-step protocol
- Safe: No inflammatory response triggered
- Protocols tailored for your application by Polyplus-transfection delivery experts
Delivery information: 10% glucose solution is included. 0,1 ml of in vivo-jetPEI®-Gal delivery reagent is sufficient to perform up to 20 intravenous injections in mouse with 50 µg of DNA.
Certifications: Since 2002, the company is ISO 9001 certified and since then this certification has been successfully renewed every three years.
Each lot of in vivo-jetPEI®-Gal is validated by DNA (pCMV-Luciferase) delivery into mouse through intravenous injection. The amount of luciferase (ng) per mg of protein is indicated on the certificate of analysis for each lot of reagent. Moreover, absence of endotoxin is verified in every lot of in vivo-jetPEI®-Gal.
Delivery information: 10% glucose solution is included. 0.1 ml of in vivo-jetPEI®-Gal delivery reagent is sufficient to perform up to 20 intravenous injections in mouse with 50 µg of DNA.